Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 2Terminated 1Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 44INDUSTRY 37NIH 3OTHER_GOV 1INDIV 1FED 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Neoplasms 3Colorectal Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Thoracic Neoplasms 1Sarcopenia 1Recurrence 1Rectal Neoplasms 1Rare Diseases 1Prostatic Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neurologic Manifestations 1Neoplasms by Site 1Neoplasm Metastasis 1Myasthenia Gravis 1Mental Disorders 1Lung Neoplasms 1Lung Diseases 1Liver Neoplasms 1Head and Neck Neoplasms 1Early Stage Lung Cancer (I and II) 1Condylomata Acuminata 1Colonic Polyps 1Colonic Neoplasms 1Carcinoma, Squamous Cell 1Carcinoma, Bronchogenic 1Cachexia 1Breast Neoplasms 1Anxiety Disorders 1Adenomatous Polyposis Coli 1

Interventions

Oxaliplatin 1Docetaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × FED × Carcinoma, Squamous Cell × Clear all
NCT00557206 2013-11-05

Oxaliplatin and Docetaxel for Recurrent or Metastatic Head and Neck Cancer

Minneapolis Veterans Affairs Medical Center

Phase 2 Terminated
35 enrolled
Head & Neck

Carcinoma, Squamous Cell, Head and Neck Neoplasms, Neoplasm Metastasis, Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡